| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00002093-199910000-00009 |
| P698 | PubMed publication ID | 10609672 |
| P50 | author | William R. Markesbery | Q56850445 |
| Marla Gearing | Q67212581 | ||
| Suzanne S. Mirra | Q67212584 | ||
| P2093 | author name string | Mori H | |
| Snowdon DA | |||
| Wolf DS | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 226-231 | |
| P577 | publication date | 1999-10-01 | |
| P1433 | published in | Alzheimer Disease and Associated Disorders | Q4738827 |
| P1476 | title | Progression of regional neuropathology in Alzheimer disease and normal elderly: findings from the Nun study. | |
| P478 | volume | 13 |
| Q89450472 | Amyloid involvement in subcortical regions predicts cognitive decline |
| Q37143766 | Apolipoprotein E e4 allele is associated with more rapid motor decline in older persons |
| Q38686493 | Apolipoprotein E4 Allele and Gait Performance in Mild Cognitive Impairment: Results From the Gait and Brain Study |
| Q30392542 | Are we prepared to deal with the Alzheimer's disease pandemic? |
| Q37477335 | Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing |
| Q38630062 | Association Between Frailty and Cognitive Impairment: Cross-Sectional Data From Toulouse Frailty Day Hospital |
| Q37306445 | Association between APOE Genotype and Change in Physical Function in a Population-Based Swedish Cohort of Older Individuals Followed Over Four Years |
| Q90464115 | Association between motoric cognitive risk syndrome and frailty among older Chinese adults |
| Q30436083 | Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve. |
| Q36395714 | Brain pathologies in extreme old age. |
| Q34554590 | Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity |
| Q38675507 | Cognitive decline and brain amyloid-β accumulation across 3 years in adults with Down syndrome |
| Q36575903 | Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature |
| Q33872703 | Cortical and subcortical cerebrovascular resistance index in mild cognitive impairment and Alzheimer's disease |
| Q47351811 | Detergent Insoluble Proteins and Inclusion Body-Like Structures Immunoreactive for PRKDC/DNA-PK/DNA-PKcs, FTL, NNT, and AIFM1 in the Amygdala of Cognitively Impaired Elderly Persons. |
| Q37942041 | Different models of frailty in predementia and dementia syndromes. |
| Q30422060 | Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study |
| Q34483878 | Early detection of Alzheimer's disease using PiB and FDG PET |
| Q40731859 | Effect of Homocysteine on Voltage-Gated Sodium Channel Currents in Primary Cultured Rat Caudate Nucleus Neurons and Its Modulation by 2-Arachidonylglycerol |
| Q34229360 | Effect of gamma-hydroxybutyrate in two rat models of focal cerebral damage |
| Q37085957 | Frequent amyloid deposition without significant cognitive impairment among the elderly |
| Q39213503 | Genomics and CSF analyses implicate thyroid hormone in hippocampal sclerosis of aging |
| Q34992164 | Hippocampal sclerosis in advanced age: clinical and pathological features. |
| Q26996741 | Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease |
| Q24302136 | In cerebrospinal fluid ER chaperones ERp57 and calreticulin bind beta-amyloid |
| Q33872248 | Is verbal episodic memory in elderly with amyloid deposits preserved through altered neuronal function? |
| Q40415499 | Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. |
| Q35064701 | Loss of motor function in preclinical Alzheimer's disease |
| Q34989491 | Microvascular damage and platelet abnormalities in early Alzheimer's disease. |
| Q36627277 | Neurons in Vulnerable Regions of the Alzheimer's Disease Brain Display Reduced ATM Signaling. |
| Q34987506 | Neuropathological and biochemical assessments of an Alzheimer's disease patient treated with the γ-secretase inhibitor semagacestat |
| Q33526568 | Neuropathology of Alzheimer's disease |
| Q38915426 | Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi |
| Q36178474 | Presence of Striatal Amyloid Plaques in Parkinson's Disease Dementia Predicts Concomitant Alzheimer's Disease: Usefulness for Amyloid Imaging |
| Q37246539 | Quantitation and mapping of cerebral detergent-insoluble proteins in the elderly |
| Q37067349 | Relationship between frailty and cognitive decline in older Mexican Americans. |
| Q36515496 | Relationship of regional brain β-amyloid to gait speed |
| Q37141423 | Striatal amyloid plaque density predicts Braak neurofibrillary stage and clinicopathological Alzheimer's disease: implications for amyloid imaging |
| Q36951533 | TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologies |
| Q35687324 | The Fox and the Rabbits-Environmental Variables and Population Genetics (1) Replication Problems in Association Studies and the Untapped Power of GWAS (2) Vitamin A Deficiency, Herpes Simplex Reactivation and Other Causes of Alzheimer's Disease |
| Q31008210 | The contribution of white matter lesions to Parkinson's disease motor and gait symptoms: a critical review of the literature |
| Q36526176 | Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta |
| Q88413710 | White Matter Reference Region in PET Studies of 11C-Pittsburgh Compound B Uptake: Effects of Age and Amyloid-β Deposition |
Search more.